无锡振华(605319) - 2025 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2025 was CNY 600,474,444.76, representing a 22.48% increase compared to CNY 490,245,147.13 in the same period last year[2]. - Net profit attributable to shareholders was CNY 94,544,684.36, up 22.20% from CNY 77,368,318.44 year-on-year[2]. - Basic earnings per share increased to CNY 0.38, reflecting a growth of 22.58% compared to CNY 0.31 in the previous year[2]. - Operating profit for Q1 2025 was ¥115,427,373.09, up 22.8% compared to ¥94,044,883.72 in Q1 2024[17]. - Net profit for Q1 2025 was ¥94,544,684.36, representing a 22.2% increase from ¥77,368,318.44 in Q1 2024[18]. - Basic and diluted earnings per share for Q1 2025 were both ¥0.38, compared to ¥0.31 in Q1 2024[18]. Cash Flow - The net cash flow from operating activities was CNY 88,424,623.01, a significant improvement from a negative cash flow of CNY -4,640,350.32 in the same period last year[2]. - Cash flow from operating activities for Q1 2025 was ¥88,424,623.01, a significant improvement from a negative cash flow of ¥4,640,350.32 in Q1 2024[21]. - The company reported a net cash outflow from investing activities of ¥63,081,711.63 in Q1 2025, compared to a net outflow of ¥43,517,222.87 in Q1 2024[22]. - Cash flow from financing activities in Q1 2025 was a net inflow of ¥119,088,113.14, compared to a net inflow of ¥14,892,167.05 in Q1 2024[22]. Assets and Liabilities - Total assets at the end of the reporting period reached CNY 5,126,760,136.97, marking a 5.64% increase from CNY 4,853,067,434.40 at the end of the previous year[3]. - The company's current assets totaled RMB 2,537,748,759.72, up from RMB 2,301,065,279.14, indicating an increase of about 10.3%[13]. - Total liabilities increased to RMB 2,594,062,963.29 from RMB 2,416,954,958.43, marking a rise of approximately 7.4%[15]. - The company's equity attributable to shareholders reached RMB 2,532,697,173.68, up from RMB 2,436,112,475.97, reflecting an increase of about 4.0%[15]. - The company’s total liabilities to equity ratio stands at approximately 1.02, indicating a balanced leverage position[15]. Shareholder Information - The top ten shareholders hold a combined 88.53% of the company's shares, with the largest shareholder owning 27.53%[9]. Research and Development - Research and development expenses for Q1 2025 amounted to ¥15,246,714.36, slightly up from ¥14,637,566.36 in Q1 2024[17]. - The company has not disclosed any new product developments or market expansion strategies in this report[1]. Inventory and Receivables - The company's inventory increased to RMB 307,714,400.83 from RMB 291,336,819.50, representing a growth of about 5.6%[13]. - Accounts receivable rose to RMB 1,516,006,470.60 from RMB 1,485,242,511.09, showing an increase of about 2.1%[13]. Non-Recurring Items - Non-recurring gains and losses amounted to CNY 2,258,509.38 after tax, primarily from government subsidies and asset disposals[5].